IPF TODAY
BREATHE, DREAM & LIVE
IPF Today
Vienna, VA
United States
info
IPF News 2019 - 2020
In the past twenty years, news on IPF was rare but in the last few years a flurry of articles has hit the news and it has accelerated in 2019 - 2020. Promising research, publications about Esbriet and Ofev, more clinical trials and a flurry of opinions of specialists have come out almost weekly. Reading all the articles provides confidence that the medical sector and pharmaceutical companies are closing in on more and better solutions.
We don't feel that we have to reproduce the idiopathic pulmonary fibrosis news here or add our views to it. That's why this page will be depending on our daily online research plus contributions of readers and will consist of the links to the news/info. If you find important information, a good article or even a hopeful sign, please let us know and we'll put the link up asap. Articles will be given the date (marked in red) we found them on the web. Just click on the blue link or copy and paste it in your address bar.
**Please understand that some articles are very technical but we have those in our list because doctors, researchers and other professions may read them.
May 31 2020 - Long after the illness is gone, the damage from coronavirus may remain
May 27 2020 - Monocyte-derived multipotent cell delivered programmed therapeutics to reverse idiopathic pulmonary fibrosis
https://advances.sciencemag.org/content/6/22/eaba3167
May 26 2020 - FDA clears 4D Medical’s lung imaging technology
https://www.massdevice.com/fda-clears-4d-medicals-lung-imaging-technology/
May 26 2020 - Stem cells from placental amniotic membrane slow lung scarring in pulmonary fibrosis
https://eurekalert.org/pub_releases/2020-05/ap-scf052220.php
May 25 2020 - OFEV® (nintedanib) now available in Canada for adults living with progressive fibrosing interstitial lung diseases (PF-ILD)(1)
May 19 2020 - FDA Awards Amplia Orphan Drug Designation for Idiopathic Pulmonary Fibrosis
May 17 2020 - Investigators Explore Seasonal Trends for Interstitial Lung Disease Hospitalizations
May 17 2020 - Pirfenidone Linked to Reduced Pulmonary Fibrosis Risks Versus Nintedanib
May 16 2020 - Redx Pharma focused on cancer and fibrosis treatment
May 14 2020 - Circulating mtDNA Is a Promising Biomarker in Idiopathic Pulmonary Fibrosis
May 10 2020 - Third Rock-backed biotech Pliant Therapeutics files for an $86 million IPO
https://www.renaissancecapital.com/Profile/PLRX/Pliant-Therapeutics/IPO
May 06 2020 - Algernon Receives First Ethics Approval for Phase 2 Ifenprodil IPF and Chronic Cough Human Study in Australia
May 04 2020 - Galecto Presents GB0139 Preclinical and Clinical Data on Anti-Fibrotic Activity as Online Experimental Biology 2020 Poster
May 02 2020 - Survival After Acute Flares of Interstitial Lung Disease Varies by Fibrosis Type, Study Says
April 27 2020 - Avalyn Pharma Secures $35.5 Million Series B Financing, Broadens Development Portfolio - aerosolized pirfenidone (AP01)
https://finance.yahoo.com/news/avalyn-pharma-secures-35-5-201200987.html
April 27 2020 - Researchers identify key mechanisms involved in pulmonary fibrosis development
https://www.eurekalert.org/pub_releases/2020-04/c-ub-rik042720.php
April 24 2020 - Lowering Mortality In Patients With Idiopathic Pulmonary Fibrosis
April 24 2020 - Characteristics of patients with chronic idiopathic interstitial pneumonia undergoing repeated respiratory-related hospitalizations: A retrospective cohort study
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0232212
April 24 2020 - Veracyte to couple Yale genomic test with its pulmonary fibrosis diagnostic
April 24 2020 - Conditional deletion of Nedd4-2 in lung epithelial cells causes progressive pulmonary fibrosis in adult mice
https://www.nature.com/articles/s41467-020-15743-6
April 22 2020 - Restless legs syndrome: A new comorbidity in idiopathic pulmonary fibrosis
https://www.resmedjournal.com/article/S0954-6111(20)30122-0/fulltext?rss=yes
April 21 2020 - 8-Puff Dry-Powder Inhaler Wins Red Dot Product Design Award
https://www.mddionline.com/8-puff-dry-powder-inhaler-wins-red-dot-product-design-award
April 20 2020 - Patient gender bias on the diagnosis of idiopathic pulmonary fibrosis
https://thorax.bmj.com/content/75/5/407
April 16 2020 - Galapagos teams up with Polish biotech Ryvu for early R&D collab
https://www.fiercebiotech.com/biotech/galapagos-teams-up-polish-biotech-ryvu-for-early-r-d-collab
April 16 2020 - What exactly are 'underlying conditions?' And why people with them may experience more serious illness from coronavirus
April 16 2020 - Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation
https://erj.ersjournals.com/content/55/4/1901760
April 14 2020 - CohBar Announces Acceptance of Late Breaking Abstract on its Antifibrotic Peptides at The American Thoracic Society 2020 International Conference
https://finance.yahoo.com/news/cohbar-announces-acceptance-breaking-abstract-123010131.html
April 09 2020 - SANUWAVE Health Announces Successful Filing of Patent for Use of Shockwaves to Treat Respiratory Ailments, Including Viral Infections Such as COVID-19
https://finance.yahoo.com/news/sanuwave-health-announces-successful-filing-180010810.html
April 08 2020 - Complete regression of pulmonary squamous carcinoma in IPF following gemcitabine plus cisplatin: a case report and literature review
https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-020-1094-1
April 08 2020 - What you need to know if you have a condition that can affect breathing
https://medicalxpress.com/news/2020-04-condition-affect.html
April 08 2020 - Lamellar Biomedical Launches Program Designed to Prevent the Severe Respiratory Effects of COVID-19, Using its Unique LAMELLASOME™ Technology
https://finance.yahoo.com/news/lamellar-biomedical-launches-program-designed-080000523.html
April 06 2020 - Pulmonary Fibrosis Foundation Statement on COVID-19
https://finance.yahoo.com/news/pulmonary-fibrosis-foundation-statement-covid-152000379.html
April 03 2020 - Increased antibiotic use correlates with higher risk for hospital admission
April 02 2020 - In-Person Testing and Signature Requirements Waived for Home Oxygen Needs
https://finance.yahoo.com/news/person-testing-signature-requirements-waived-155200308.html
April 02 2020 - Algernon Pharmaceuticals gives old drugs new meanings to fight
March 24 2020 - Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseases.
March 24 2020 - Finding the best method to grow bioengineered tissue for pulmonary research
https://news.yale.edu/2020/03/24/finding-best-method-grow-bioengineered-tissue-pulmonary-research
March 24 2020 - Bacterial protein fragment kills lung cells in pulmonary fibrosis, study finds
https://news.illinois.edu/view/6367/807422
March 23 2020 - Bayer signs €250m pact with India’s Curadev for STING drugs
http://www.pmlive.com/pharma_news/bayer_signs_250m_pact_with_indias_curadev_for_sting_drugs_1329793
March 20 2020 - OliX Pharmaceuticals Advances RNAi Approaches to Target Highly Conserved Regions of Coronavirus RNAs
https://finance.yahoo.com/news/olix-pharmaceuticals-advances-rnai-approaches-140010232.html
March 20 2020 - Complete regression of pulmonary squamous carcinoma in IPF following gemcitabine plus cisplatin: a case report and literature review
https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-020-1094-1
March 14 2020 - Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-020-1103-4
March 12 2020 - Hepion Pharmaceuticals' CRV431 Demonstrates Efficacy in Human Idiopathic Pulmonary Fibrosis Translational Research Study
https://finance.yahoo.com/news/hepion-pharmaceuticals-crv431-demonstrates-efficacy-121500213.html
March 11 2020 - Gilead/Galapagos, Intercept and Corbus trials could be hit by coronavirus spread: analyst
March 10 2020 - FDA clears wider use for Boehringer’s Ofev in lung disease
http://www.pmlive.com/pharma_news/fda_clears_wider_use_for_boehringers_ofev_in_lung_disease_1328600
March 09 2020 - Experimental Fibrosis Drug May Help Immuno-Oncology Therapies
https://www.biospace.com/article/experimental-fibrosis-drug-may-help-immuno-oncology-therapies/
March 06 2020 - Algernon Announces Availability of its NP-120 Ifenprodil Drug for Compassionate Use for Coronavirus
March 05 2020 - 5 Questions About Transbronchial Lung Cryobiopsy for Diagnosing ILD
March 04 2020 - Pulmonary Fibrosis Foundation, Celgene Form Biomarker Consortium
March 03 2020 - High-flow nasal cannula oxygen therapy in idiopathic pulmonary fibrosis patients with respiratory failure
http://jtd.amegroups.com/article/view/36576/html
February 28 2020 - Scientists discover three genes associated with fatal lung disease
https://www.eurekalert.org/pub_releases/2020-02/nifh-sdt022820.php
February 28 2020 - Tyler doctors advance clinical trials for drug that helps reverse lung scarring
February 28 2020 - Inhalation Therapy Shows Promise Against Pulmonary Fibrosis in Mice, Rats
https://news.ncsu.edu/2020/02/inhalation-therapy-ipf/
February 24 2020 - 86% of Americans Do Not Know Symptoms of Pulmonary Fibrosis
https://finance.yahoo.com/news/86-americans-not-know-symptoms-153000087.html
February 19 2020 - Right single lung transplantation using an inverted left donor lung: interposition of pericardial conduit for pulmonary venous anastomosis - a case report
https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-020-1075-4
February 19 2020 - Anti-Fibrotic Activity of Hepion Pharmaceuticals’ CRV431 Shows Potential to Extend to Multiple Organs and Fibrotic Diseases
February 19 2020 - Thrombomodulin Alfa Not Recommended for Idiopathic Pulmonary Fibrosis
February 14 2020 - Knowledge About Effective Therapies for Interstitial Lung Disease Lacking, Review Says
February 13 2020 - Idiopathic Pulmonary Fibrosis Annualized Costs Totals More Than $10,000 Per Patient
February 13 2020 - University City Science Center partnership with CSL Behring accelerates the search for new biotherapies at the University of Pittsburgh and the University of Delaware
February 13 2020 - ATS Foundation Research Program announces unrestricted grant recipients for the 2019 cycle
https://www.eurekalert.org/pub_releases/2020-02/ats-afr021320.php
February 12 2020 - New Aust technology to treat lung disease
https://7news.com.au/news/health/new-aust-technology-to-treat-lung-disease-c-694068
February 10 2020 - Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry
https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-020-1315-4
February 10 2020 - Prognostic Value of Serum Osteopontin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
https://www.hindawi.com/journals/bmri/2020/3424208/
February 07 2020 - Aryl hydrocarbon receptor signals attenuate lung fibrosis in the bleomycin-induced mouse model for pulmonary fibrosis through increase of regulatory T cells
https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-020-2112-7
February 04 2020 - Bristol-Myers launches biotech targeting fibrosis, inflammation
https://www.biopharmadive.com/news/bristol-myers-biomotive-launch-anteros-biotech/571650/
February 03 2020 - Shilpa Medicare share price gains nearly 6% on USFDA nod
January 31 2020 - Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis
https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-020-1060-y
January 31 2020 - Scientists describe genetic program behind primordial lung progenitors
January 30 2020 - RCSI: Lung disease cures boosted with growth of long-lasting stem cells
https://www.siliconrepublic.com/innovation/rcsi-lung-diseases-stem-cells
January 29 2020 - Lung Microbiome Found to Predict Outcomes in Critically Ill Patients
https://www.ajmc.com/newsroom/lung-microbiome-found-to-predict-outcomes-in-critically-ill-patients
January 28 2020 - Automated Computed Tomography analysis in the assessment of Idiopathic Pulmonary Fibrosis severity and progression
https://www.ejradiology.com/article/S0720-048X(20)30041-3/fulltext?rss=yes
January 27 2020 - MediciNova Receives Notice of Intention to Grant for New Patent Covering MN-001 for the Treatment of Idiopathic Pulmonary Fibrosis in Europe
https://finance.yahoo.com/news/medicinova-receives-notice-intention-grant-230010194.html
January 25 2020 - Nintedanib Exhibits Superior Cost-effectiveness to Pirfenidone for Treatment of IPF, Study Finds
January 21 2020 - Lung Microbiome May Help Predict Outcomes in Critically Ill Patients
January 21 2020 - Too much stretching is bad for the lungs
https://stke.sciencemag.org/content/13/615/eaba9167
January 17 2020 - Emerging Therapeutic Innovations for Treatment of Idiopathic Pulmonary Fibrosis
January 15 2020 - Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls
https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-020-1275-8
January 15 2020 - Screening for YAP Inhibitors Identifies Statins as Modulators of Fibrosis
https://www.atsjournals.org/doi/10.1165/rcmb.2019-0296OC
January 15 2020 - Galapagos bags option on 4 more Fibrocor programs
https://www.fiercebiotech.com/biotech/galapagos-bags-option-four-more-fibrocor-programs
January 14 2020 - Airway epithelial specific deletion of Jun-N-terminal kinase 1 attenuates pulmonary fibrosis in two independent mouse models
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0226904
January 14 2020 - Rx Globally Patented Non-Steroidal Nasal Spray for All Lung Diseases including Pulmonary Fibrosis, CF, COPD, Unmet Needs with No Known Side Effects that can also be used to Deliver Antivirals, Antimicrobials, Insulin, and other Drugs
January 09 2020 - Boehringer Ingelheim, Enleofen Ink $1B-Per-Product Anti-IL-11 Partnership Focused on NASH, Lung Disorders
January 09 2020 - Redx Pharma Nominates Another Anti-Fibrosis Drug Candidate
January 07 2020 - Ark Biosciences to Present at JPM Healthcare Conference in San Francisco
January 06 2020 - Galecto and PharmAkea Merge to Create Strong Clinical-Stage Company Developing First-in-Class Therapeutics in Fibrosis and Cancer
https://finance.yahoo.com/news/galecto-pharmakea-merge-create-strong-063010159.html
December 30 2019 - The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis
https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-019-1032-2
December 30 2019 - Short or long sleep associated with Pulmonary Fibrosis
https://medicalxpress.com/news/2019-12-short-pulmonary-fibrosis.html
December 24 2019 - Nuformix Reports "Significant Progress" In Half-Year As Loss Narrows
December 18 2019 - Angion Initiates Dosing in Phase 1 Clinical Trial Evaluating ANG-3070, a Dual-Kinase Inhibitor for the Treatment of Fibrotic Diseases
https://finance.yahoo.com/news/angion-initiates-dosing-phase-1-150010346.html
December 17 2019 - Hexokinase 2 couples glycolysis with the profibrotic actions of TGF-β
https://stke.sciencemag.org/content/12/612/eaax4067.full
December 17 2019 - Forced Vital Capacity (FVC) decline, mortality and healthcare resource utilization in idiopathic pulmonary fibrosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968594/
December 16 2019 - CohBar Confirms Anti-fibrotic Effect of a Novel Peptide in a Therapeutic Model of Idiopathic Pulmonary Fibrosis
December 12 2019 - miRagen Restructures to Focus on Fibrosis, Inks $20M Stock Deal
December 12 2019 - Glycogen Synthase Kinase-3β Inhibition with 9-ING-41 Attenuates the Progression of Pulmonary Fibrosis
https://www.nature.com/articles/s41598-019-55176-w
December 10 2019 - Researchers create accurate model of organ scarring using stem cells in a lab
https://newsroom.ucla.edu/releases/model-organ-scarring-stem-cells-fibrosis
December 09 2019 - Algernon Pharmaceuticals Selects NP-120 (Ifenprodil) for its Lead Phase 2 Trial for Idiopathic Pulmonary Fibrosis and Chronic Cough
December 06 2019 - Idiopathic Pulmonary Fibrosis Susceptibility Identified Via Genomic Markers
December 04 2019 - With cellular blueprint for lungs, Yale researchers look ahead to organ regeneration
https://news.yale.edu/2019/12/04/cellular-blueprint-lungs-researchers-look-organ-regeneration
December 04 2019 - MUC1 intracellular bioactivation mediates lung fibrosis
https://thorax.bmj.com/content/75/2/132
December 03 2019 - Genkyotex Reports Progress of Setanaxib Phase 2 Investigator Initiated Trials
https://finance.yahoo.com/news/genkyotex-reports-progress-setanaxib-phase-120010023.html
December 03 2019 - Chronic Viral Infection May Increase Idiopathic Pulmonary Fibrosis Risk
December 02 2019 - BioMed X Reaches Milestone in Respiratory Disease Research Collaboration with Boehringer Ingelheim
December 01 2019 - Clinic pitches unproven treatments to desperate patients, with tips on raising the cash
November 27 2019 - Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis
https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-019-0986-4
November 27 2019 - Gender differences at presentation of idiopathic pulmonary fibrosis in Sweden
https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-019-0994-4
November 27 2019 - Health Canada approves OFEV (nintedanib), the first and only therapy in Canada to slow the rate of decline in pulmonary function in patients with systemic sclerosis associated ILD
November 26 2019 - Portable normothermic organ care system may increase number of lungs available for transplant
November 26 2019 - Perioperative pirfenidone treatment for lung cancer patients with idiopathic pulmonary fibrosis
https://link.springer.com/article/10.1007/s00595-019-01923-5
November 25 2019 - Algernon Pharmaceuticals Provides Update on its Planned Phase II Clinical Trial
https://finance.yahoo.com/news/algernon-pharmaceuticals-provides-planned-phase-120010646.html
November 22 2019 - TFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA)
November 22 2019 - The forgotten victims of Sept. 11: Survivors, not responders, also need health help
November 20 2019 - Debenone has preventative and therapeutic effects on pulmonary fibrosis via preferential suppression of fibroblast activity
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861265/
November 20 2019 - Burden of Idiopathic Pulmonary Fibrosis in Canada report sheds light on barriers to treatment and resources for Canadians living with this debilitating condition
November 15 2019 - After BMS said no, Roche puts $1.4B on the table for Promedior, boosting fibrotic pipeline
November 14 2019 - Yale study provides insights into how fibrosis progresses in the human lung
https://news.yale.edu/2019/11/14/yale-study-provides-insights-how-fibrosis-progresses-human-lung
November 13 2019 - Trevi Therapeutics to Present at Stifel Healthcare Conference
November 12 2019 - Translocation of TRPV4-PI3Kγ complexes to the plasma membrane drives myofibroblast transdifferentiation
https://stke.sciencemag.org/content/12/607/eaau1533.full
November 12 2019 - Research points to possible target to treat idiopathic pulmonary fibrosis, or IPF
https://www.eurekalert.org/pub_releases/2019-11/uoaa-rpt111219.php
November 07 2019 - Targeting inflammatory sites through collagen affinity enhances the therapeutic efficacy of anti-inflammatory antibodies
https://advances.sciencemag.org/content/5/11/eaay1971
November 07 2019 - New analysis of patients with autoimmune-related ILDs in the INBUILD study shown as poster presentation at the 2019 ACR/ARP Annual Meeting
https://finance.yahoo.com/news/analysis-patients-autoimmune-related-ilds-140000891.html
November 05 2019 - Inhaled nitric oxide improves exercise capacity in patients at risk for pulmonary fibrosis-related pulmonary hypertension
November 05 2019 - Crystecpharma and Iconovo to collaborate in development of innovative inhaler products
November 04 2019 - NIH Awards Major Grant In Pulmonary Fibrosis Research
November 01 2019 - Pulmonary Fibrosis Foundation (PFF) Summit 2019
October 30 2019 - Scientists reverse fibrosis in preclinical studies
https://medicalxpress.com/news/2019-10-scientists-reverse-fibrosis-preclinical.html
October 29 2019 - Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry
October 25 2019 - The relationship between MUC5B promoter, TERT polymorphisms and telomere lengths with radiographic extent and survival in a Chinese IPF cohort
https://www.nature.com/articles/s41598-019-51902-6
October 24 2019 - Patient Costs of IPF Care Better with Pirfenidone than Nintedanib
https://www.mdmag.com/medical-news/costs-ipf-care-pirfenidone-nintedanib
October 23 2019 - IPF Biomarkers Modulated by Use of Antifibrotic Therapy
https://www.mdmag.com/medical-news/costs-ipf-care-pirfenidone-nintedanib
October 21 2019 - Transforming growth factor beta 1 induces methylation changes in lung fibroblasts
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0223512
October 21 2019 - Oxygen Therapy Is Associated with Poor Patient-Reported Outcomes in COPD and IPF
October 21 2019 - Indalo Therapeutics Initiates Dosing in IPF Patients with Lead Antifibrotic Drug Candidate IDL-2965
October 19 2019 - ILD Associated With More Muscle Mass, Less Bone Density Loss
October 18 2019 - Altavant Sciences to Present Data Supporting Once-Daily Dosing of Rodatristat Ethyl at CHEST 2019
https://finance.yahoo.com/news/altavant-sciences-present-data-supporting-203000145.html
October 17 2019 - Study lays groundwork for understanding RA-ILD/RA-IPF overlap
October 17 2019 - Steve Jones, Chair Action for Pulmonary Fibrosis and Board Member EU-IPFF and Gisli Jenkins from Nottingham University Hospitals, explain idiopathic pulmonary fibrosis (IPF), an incurable lung disease
https://www.openaccessgovernment.org/incurable-lung-disease/75958/
October 15 2019 - Eleusis Announces Published Research on Potential of Serotonin 2A Receptor Agonists to Treat Inflammation
October 15 2019 - Two-for-one PET tracer reveals early signs of pancreatic cancer — and, unexpectedly, lung disease
October 15 2019 - Pliant Therapeutics Announces Publication Demonstrating Feasibility of Positron Emission Tomography (PET) Tracers for Imaging Fibrosis in Patients with Idiopathic Pulmonary Fibrosis
October 14 2019 - Increased flux through the mevalonate pathway mediates fibrotic repair without injury
https://www.jci.org/articles/view/127959
October 11 2019 - New transplant research aims to salvage infected donated organs
October 10 2019 - Decrements of body mass index are associated with poor outcomes of idiopathic pulmonary fibrosis patients
October 10 2019 - Researchers identify new therapeutic target for pulmonary fibrosis
https://www.eurekalert.org/pub_releases/2019-10/rup-rin100719.php
October 10 2019 - Epigenetic Changes to Gene Affect Key Cells Behind Idiopathic Pulmonary Fibrosis
October 10 2019 - New therapeutic target identified for pulmonary fibrosis
https://www.drugtargetreview.com/news/50668/therapeutic-target-pulmonary-fibrosis/
October 09 2019 - UD engineering professor receives NIH grant to accelerate study of lung fibrosis
October 09 2019 - New data showed OFEV (nintedanib) slows decline of lung function in broad range of chronic fibrosing interstitial lung diseases with a progressive phenotype(1)
October 08 2019 - Pamrevlumab may be safe, effective in IPF
October 08 2019 - Biogen Strengthens MS & SMA Portfolio as Competition Lurks
https://finance.yahoo.com/news/biogen-strengthens-ms-sma-portfolio-123312716.html
October 07 2019 - MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Idiopathic Pulmonary Fibrosis in Japan
October 07 2019 - Is home spirometry a reliable tool for managing idiopathic pulmonary fibrosis?
October 04 2019 - Scientists ID new targets to treat fibrosis—a feature of many chronic diseases
https://medicalxpress.com/news/2019-10-scientists-id-fibrosisa-feature-chronic.html
October 022019 - Xylyx Bio announces development of disease-specific cell culture products to accelerate anti-fibrotic drug discovery and screening
October 01 2019 - MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of Idiopathic Pulmonary Fibrosis in China
October 01 2019 - Crystal Genomics confirms efficacy of epigenetics-based pulmonary fibrosis treatment
http://www.koreabiomed.com/news/articleView.html?idxno=6522
September 30 2019 - INBUILD® meets primary endpoint: study evaluated Ofev® in patients across a range of progressive fibrosing interstitial lung diseases
September 30 2019 - FibroGen Announces Publication in the Lancet Respiratory Medicine of Positive Pamrevlumab Efficacy and Safety Data for the Praise Phase 2 Study in Idiopathic Pulmonary Fibrosis
September 30 2019 - Bridge Biotherapeutics Presents Positive Results from Phase 1 Clinical Study of BBT-877 for Idiopathic Pulmonary Fibrosis (IPF) Treatments at the ERS International Congress 2019
September 29 2019 - IPF: New Approach May Hold Potential For Treating This Fatal Lung Condition
September 27 2019 - Concomitant Medications and Clinical Outcomes in Idiopathic Pulmonary Fibrosis
https://erj.ersjournals.com/content/erj/early/2019/08/29/13993003.01188-2019.full.pdf
September 26 2019 - Risk for developing idiopathic pulmonary fibrosis up in IBD
https://medicalxpress.com/news/2019-09-idiopathic-pulmonary-fibrosis-ibd.html
September 26 2019 - Possible target found for idiopathic pulmonary fibrosis treatment
https://www.drugtargetreview.com/news/49940/target-idiopathic-pulmonary-fibrosis-treatment/
September 25 2019 - Blade Therapeutics Expands Anti-Fibrotic Pipeline With Acquisition of ATXCo and Its Autotaxin Inhibitor (PAT-409)
https://www.blademed.com/news/sept-25-2019/
September 25 2019 - Promising steps towards a treatment for pulmonary fibrosis
https://medicalxpress.com/news/2019-09-treatment-pulmonary-fibrosis.html
September 22 2019 - Citryll collaborates with leading Neutrophil Extracellular Trap researcher Dr. Markus Hoffmann
September 17 2019 - Cross-Talk between Transforming Growth Factor-β and Periostin Can Be Targeted for Pulmonary Fibrosis
https://www.atsjournals.org/doi/abs/10.1165/rcmb.2019-0245OC
September 17 2019 - Yale researchers demystify lung pressure sensors in the immune response
September 17 2019 - Biogen axes phase 2 study of lung-scarring med due to 'safety concerns'
September 16 2019 - Bellerophon's nitric oxide an Orphan Drug in U.S. for IPF
https://seekingalpha.com/news/3499452-bellerophons-nitric-oxide-orphan-drug-in-u-s-for-ipf
September 16 2019 - AdAlta (ASX:1AD) targeting idiopathic pulmonary fibrosis
https://www.finnewsnetwork.com.au/archives/finance_news_network263982.html
September 16 2019 - The role of eHealth tools in idiopathic pulmonary fibrosis care and research
https://www.openaccessgovernment.org/ehealth-idiopathic-pulmonary-fibrosis/73433/
September 11 2019 - U.S. Stem Cell destruction postponed while ruling is appealed
September 10 2019 - Gene coding error found in rare, inherited gene cof lung-scarring disorder linked to short telomeres
https://medicalxpress.com/news/2019-09-gene-coding-error-rare-inherited.html
September 06 2019 - A fatal lung disease has met its match at CU Anschutz
https://news.cuanschutz.edu/news-stories/a-fatal-lung-disease-has-met-its-match-at-cu-anschutz
September 05 2019 - Patient Group Advances Clinical Trials, Diverts Patients From Unregulated Therapies
September 04 2019 - Three Lakes Partners And Pulmonary Fibrosis Foundation Partner In Fight Against Pulmonary Fibrosis
https://finance.yahoo.com/news/three-lakes-partners-pulmonary-fibrosis-153800783.html
September 03 2019 - Kiel University and Hovione to develop high-dose inhalation formulations
https://finance.yahoo.com/news/processa-pharmaceuticals-announces-licensing-anti-133000241.html
September 03 2019 - Processa Pharmaceuticals Announces the Licensing Of An Anti-Fibrotic, Anti-Inflammatory Drug For The Treatment Of Multiple Unmet Medical Need Conditions
https://finance.yahoo.com/news/processa-pharmaceuticals-announces-licensing-anti-133000241.html
September 03 2019 - GDF15 is an epithelial-derived biomarker of idiopathic pulmonary fibrosis
https://journals.physiology.org/doi/full/10.1152/ajplung.00062.2019
August 30 2019 – Idiopathic pulmonary fibrosis in small cell lung cancer as a predictive factor for poor clinical outcome and risk of its exacerbation
August 28 2019 – Taiwan researchers discover key to reversing lung disease in mice
http://focustaiwan.tw/news/asoc/201908280025.aspx
August 21 2019 – Pressure regulates immune-cell function
https://www.nature.com/articles/d41586-019-02339-4
August 21 2019 – Schrodinger extends drug discovery partnership with Morphic
August 21 2019 – Increased risk of idiopathic pulmonary fibrosis in inflammatory bowel disease: A nationwide study
August 21 2019 – Mechanosensation of cyclical force by PIEZO1 is essential for innate immunity
https://www.nature.com/articles/s41586-019-1485-8
August 19 2019 – Emerging Therapies for Interstitial Lung Disease
August 19 2019 – Total extract of Xin Jia Xuan Bai Cheng Qi decoction inhibits pulmonary fibrosis via the TGF-β/Smad signaling pathways in vivo and in vitro
August 15 2019 – EmphyCorp Inc. FDA Submission for Rx New Non-Steroidal Nasal Spray for Pulmonary Fibrosis w/ No Known Side Effects
https://finance.yahoo.com/news/emphycorp-inc-fda-submission-rx-140800165.html
August 14 2019 – Korean firms eyeing on growing orphan drug market
http://www.koreabiomed.com/news/articleView.html?idxno=6280
August 14 2019 – Kadmon (KDMN) Completes Enrollment in KD025 Study for cGVHD
https://finance.yahoo.com/news/kadmon-kdmn-completes-enrollment-kd025-131001943.html
August 13 2019 – Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
August 13 2019 – Daewoong's idiopathic pulmonary fibrosis treatment wins orphan drug status
http://www.koreabiomed.com/news/articleView.html?idxno=6273
August 11 2019 – Hidden dangers: How cleaning products could be harming your lung health
https://startsat60.com/health/health-issues/lung-health/cleaning-products-bad-dangerous-lung-health
August 8 2019 – An atypical pulmonary fibrosis is associated with co-inheritance of mutations in the calcium binding protein genes S100A3 and S100A13
https://erj.ersjournals.com/content/54/1/1802041
August 7 2019 – Effects of IPF combination therapy similar for patients with, without right heart dysfunction
August 7 2019 – Q&A with Pulmocide CEO Garth Rapeport – Why Pulmocide is developing targeted lung therapy
August 7 2019 – Outcomes following decline in forced vital capacity in patients with idiopathic pulmonary fibrosis: Results from the INPULSIS and INPULSIS-ON trials of nintedanib
August 7 2019 – Autophagy inhibition-mediated epithelial–mesenchymal transition augments local myofibroblast differentiation in pulmonary fibrosis
https://www.nature.com/articles/s41419-019-1820-x
August 6 2019 – FLASH radiotherapy: from preclinical promise to the first human treatment
August 1 2019 – Vancouver company repurposes Soviet Union doping drug to cure kidney disease
July 29 2019 – Anti-fibrotic effects of tannic acid through regulation of a sustained TGF-beta receptor signaling
https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-019-1141-8
July 27 2019 – PF Warriors and Responsum Health Announce Strategic Alliance
July 26 2019 – A Patient's Guide To Pulmonary Fibrosis
https://health.usnews.com/conditions/pulmonary-fibrosis
July 25 2019 – Priyanka Chopra 'proud' As 'The Sky Is Pink' Set For Toronto International Film Festival 2019 Premiere
July 23 2019 – Medical Centers Specialize To Treat Patients With Complex Lung Disease
July 22 2019 – Significance of interstitial lung disease on outcomes following cardiac surgery
July 22 2019 – FibroGen Announces First Patient Dosed in ZEPHYRUS, a Phase 3 Clinical Trial of Pamrevlumab for the Treatment of Patients with Idiopathic Pulmonary Fibrosis
July 19 2019 – Improving Outcomes and Managing Costs in Idiopathic Pulmonary Fibrosis
July 19 2019 – Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape
July 18 2019 – Bridge Biotherapeutics licenses out IPF treatment candidate to Boehringer
http://www.koreabiomed.com/news/articleView.html?idxno=6126
July 18 2019 – Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF)
https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-019-0895-6
July 17 2019 – Rare inherited enzyme disorder yields insight into fibrosis
https://www.sciencedaily.com/releases/2019/07/190717142655.htm
July 17 2019 – Shaky scaffold changes lung infrastructure
https://www.eurekalert.org/pub_releases/2019-07/tju-ssc071719.php
July 17 2019 – Genkyotex Announces FDA Approval of Phase 2 Investigator-Initiated Trial with GKT831 in IPF
https://finance.yahoo.com/news/genkyotex-announces-fda-approval-phase-050000488.html
July 15 2019 – Gilead Pays Billions for Access to Galapagos’ Pipeline
https://www.labiotech.eu/medical/gilead-galapagos-arthritis-pulmonary-fibrosis/
July 152019 – Clinical Effectiveness of Antifibrotic Medications for Idiopathic Pulmonary Fibrosis
https://www.atsjournals.org/doi/abs/10.1164/rccm.201902-0456OC?af=R&
July 10 2019 – Clinical significance of autoantibody positivity in idiopathic pulmonary fibrosis
July 9 2019 – Kither Biotech Raises €5.6M in Financing
http://www.finsmes.com/2019/07/kither-biotech-raises-e5-6m-in-financing.html
July 5 2019 – Dutch Antibodies for Autoimmune Diseases Boosted by €15M Series A
https://www.labiotech.eu/medical/citryll-autoimmune-disease-lupus-arthritis/
July 5 2019 – Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in North American patients with idiopathic pulmonary fibrosis
July 3 2019 – Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis
https://www.nature.com/articles/s41467-019-10839-0
July 4 2019 – Dangerous weedkiller still used despite ban
July 3 2019 – Algernon Pharmaceuticals’ NP-120 Reduced Fibrosis in an Idiopathic Pulmonary Fibrosis Study by 56% Outperforming USFDA Approved Treatments Nintedanib and Pirfenidone
July 1 2019 – Genkyotex’s GKT831 Prevents Multiple Complications of Portal Hypertension in Preclinical Model
https://finance.yahoo.com/news/genkyotex-gkt831-prevents-multiple-complications-050000410.html
June 4 2019 – Gli signaling pathway modulates fibroblast activation and facilitates scar formation in pulmonary fibrosis
https://www.sciencedirect.com/science/article/pii/S0006291X19308794?via%3Dihub
June 28 2019 – A complete guide to home nebulizer therapy
https://www.medicalnewstoday.com/articles/325607.php
June 28 2019 – A new target for the treatment of Idiopathic Pulmonary Fibrosis
June 27 2019 – Pliant Therapeutics Reports Positive Results of Phase 1b Clinical Study Supporting Advancement of PLN-74809 for Treatment of Idiopathic Pulmonary Fibrosis
June 26 2019 – Mobile Health Monitoring in Patients with Idiopathic Pulmonary Fibrosis
https://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.201904-335RL
June 25 2019 – Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppression of TGF-β1 production and TGF-β1-induced fibroblast differentiation
https://www.sciencedirect.com/science/article/pii/S156757691930387X?via%3Dihub
June 25 2019 – Many Docs at Stem Cell Clinics Lack Specific Training
June 25 2019 – Adding clinical variables improves accuracy of lung allocation score
https://medicalxpress.com/news/2019-06-adding-clinical-variables-accuracy-lung.html
June 24 2019 – Novel idiopathic pulmonary fibrosis susceptibility variants revealed by deep sequencing
https://openres.ersjournals.com/content/5/2/00071-2019
June 24 2019 – Dysregulated expression of hypoxia-inducible factors augments myofibroblasts differentiation in idiopathic pulmonary fibrosis
https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-019-1100-4
June 21 2019 – 13 Signs Your Lungs May Not Be Healthy
https://parade.com/893333/nicolepajer/13-signs-your-lungs-may-not-be-healthy/
June 20 2019 – Short-Term Effectiveness of Antifibrotics in Idiopathic Pulmonary Fibrosis
June 18 2019 – Children's interstitial and diffuse lung disease
https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(19)30117-8/fulltext
June 17 2019 – Is Sooner Better? The Push to Use Antifibrotics Early in IPF
https://www.medscape.com/viewarticle/913754
June 17 2019 – Fast Five Quiz: Diagnosing Idiopathic Pulmonary Fibrosis
https://reference.medscape.com/viewarticle/909154
June 14 2019 – Differences in tolerability of pirfenidone between elderly and younger patients with idiopathic pulmonary fibrosis
June 14 2019 – Innovative technology saves lives, lungs at Cleveland Clinic
June 12 2019 – British Lung Foundation: Scotland's opt-out law 'strikes right balance'
June 12 2019 – WVU and NIOSH study ways to prevent lung disease in dentistry professionals
https://www.eurekalert.org/pub_releases/2019-06/wvu-wan061219.php
June 12 2019 – Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in North American patients with idiopathic pulmonary fibrosis
June 6 2019 – High-flow nasal cannula oxygen therapy to treat acute respiratory failure in patients with acute exacerbation of idiopathic pulmonary fibrosis
https://journals.sagepub.com/doi/full/10.1177/1753466619847130
June 6 2019 – Nintedanib Discontinuation in Idiopathic Pulmonary Fibrosis Related to Anorexia
June 4 2019 – Lung Therapeutics, Inc. Raises $36 Million in Series C Financing to Advance Clinical Pipeline
https://finance.yahoo.com/news/lung-therapeutics-inc-raises-36-100000037.html
June 4 2019 – Systematic review and meta-analysis of clinical significance of autoantibodies for idiopathic pulmonary fibrosis
June 3 2019 – Reviva Pharmaceuticals Announces Successful Completion of Pre-IND Meeting with FDA on Brilaroxazine for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
June 3 2019 – Support for a Calcium-Based Therapeutic Approach in Pulmonary Fibrosis
May 31 2019 – Occupational Hazards Account for More than One in Ten People with Range of Lung Diseases
May 31 2019 – Morphic joins May biotech IPO push with $86M goal
May 31 2019 – Patient-directed YouTube videos on idiopathic pulmonary fibrosis often misleading
May 30 2019 – Pulmonary Fibrosis Patient Registry Research Presented At American Thoracic Society Conference
May 23 2019 – Interstitial Lung Disease (ILD) Experts And Advocates Announce Formation Of Open Source Imaging Consortium (OSIC)
May 23 2019 – Prognostic Effects of Imaging Ratios in Idiopathic Pulmonary Fibrosis
May 22 2019 – Researchers discovered that a receptor vital to iron processing in the lungs is much less common in patients with idiopathic pulmonary fibrosis (IPF)
https://www.imperial.ac.uk/news/191277/missing-iron-receptors-predict-lung-disease/
May 21 2019 – Naftopidil reduced the proliferation of lung fibroblasts and bleomycin‐induced lung fibrosis in mice
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484423/
May 21 2019 – Phase III study showed Ofev® slows the loss of pulmonary function in people living with systemic sclerosis associated ILD
https://finance.yahoo.com/news/phase-iii-study-showed-ofev-160500828.html
May 21 2019 - Serum prealbumin is a prognostic indicator in idiopathic pulmonary fibrosis
May 20 2019 – Promedior Announces Positive Long-term Safety and Efficacy Data from Open Label Extension Study of PRM-151 in Idiopathic Pulmonary Fibrosis
https://finance.yahoo.com/news/promedior-announces-positive-long-term-153000315.html
May 20 2019 – Idiopathic Pulmonary Fibrosis Outcomes Similar With Pneumonia or Acute Exacerbation
May 20 2019 – Respivant Sciences Announces Dosing of First Patient in Phase 2b Trial of RVT-1601 for the Treatment of Persistent Cough Due to Idiopathic Pulmonary Fibrosis
https://finance.yahoo.com/news/respivant-sciences-announces-dosing-first-120000258.html
May 20 2019 – Bridge Biotherapeutics Announces Data Presentation from First-in-Human Study of BBT-877 for Idiopathic Pulmonary Fibrosis
https://finance.yahoo.com/news/bridge-biotherapeutics-announces-data-presentation-003800654.html
May 18 2019 – Concurrent Decline in FVC, Walking Test More Likely Associated With Disease Progression in IPF
May 14 2019 – Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosis
https://www.sciencedirect.com/science/article/pii/S108986031930076X?via%3Dihub
May 142019 – Elevation of IL-6 and IL-33 Levels in Serum Associated with Lung Fibrosis and Skeletal Muscle Wasting in a Bleomycin-Induced Lung Injury Mouse Model
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458868/
May 13 2019 – Distribution of emphysema and fibrosis in idiopathic pulmonary fibrosis with coexisting emphysema
May 11 2019 – Visual and automated CT measurements of lung volume loss in idiopathic pulmonary fibrosis
May 11 2019 – How work on erectile dysfunction could cure a deadly lung disease
May 11 2019 – Noninvasive imaging of tumor progression, metastasis, and fibrosis using a nanobody targeting the extracellular matrix
May 11 2019 – Interstitial pneumonia may be new category of undifferentiated connective tissue disease
May 11 2019 – Protective effects of Rosavin on bleomycin-induced pulmonary fibrosis via suppressing fibrotic and inflammatory signaling pathways in mice
https://www.sciencedirect.com/science/article/pii/S0753332219305785?via%3Dihub
May 10 2019 - Cigarette smoke exposure combined with lipopolysaccharides induced pulmonary fibrosis in mice
https://www.sciencedirect.com/science/article/pii/S1569904818304324?via%3Dihub
May 09 2019 - Gastroesophageal reflux and antacid therapy in IPF: Analysis from the Australia IPF Registry
May 09 2019 - 'Bad guy' fibrocytes could help rebuild damaged tissue
https://medicalxpress.com/news/2019-05-bad-guy-fibrocytes-rebuild-tissue.html
April 30 2019 - New insights on link between common lung diseases and cardiovascular risk
April 30 2019 - Guest commentary: Examining cognitive bias in disease management conversations
April 30 2019 - AstraZeneca signs on BenevolentAI for lung, kidney drug discovery work
April 26 2019 - Paragonix and the Lung Transplant Foundation Announce Expansion of Partnership to Accelerate Commercialization of Innovative Lung Preservation Technologies
https://finance.yahoo.com/news/paragonix-lung-transplant-foundation-announce-155300245.html
April 24 2019 - UVM researchers making strides in treating rare lung disease
April 23 2019 - Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
https://www.ncbi.nlm.nih.gov/pubmed/30616998
April 22 2019 - A word of caution on stem cell therapies for pulmonary fibrosis
https://medicalnewsbulletin.com/caution-stem-cell-therapies-pulmonary-fibrosis/
April 18 2019 - IL-25 contributes to lung fibrosis by directly acting on alveolar epithelial cells and fibroblasts
https://journals.sagepub.com/doi/10.1177/1535370219843827
April 18 2019 - Indalo Therapeutics Initiates Dosing in Phase 1 Clinical Trial of Lead Antifibrotic Drug Candidate IDL-2965
April 15 2019 - Long intergenic non-coding RNAs regulate human lung fibroblast function: Implications for idiopathic pulmonary fibrosis
https://www.nature.com/articles/s41598-019-42292-w
April 12 2019 - Lung transplant outcomes in pulmonary fibrosis patients with telomere-related gene variants
April 11 2019 - Negative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosis
https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-019-0841-7
April 10 2019 - Molecular classifier helps spot idiopathic pulmonary fibrosis
https://www.mdlinx.com/pulmonology/top-medical-news/article/2019/04/10/7563621/
April 10 2019 - Vimentin intermediate filament assembly regulates fibroblast invasion in fibrogenic lung injury
https://insight.jci.org/articles/view/123253
April 10 2019 - 5-minute breathing 'workout' may benefit heart and brain health
https://www.medicalnewstoday.com/articles/324928.php
April 10 2019 - A 2-year observational study in patients suffering from idiopathic pulmonary fibrosis and treated with pirfenidone: A French Ancillary Study of PASSPORT
April 9 2019 - What can cause a dry cough?
https://www.medicalnewstoday.com/articles/324912.php
April 9 2019 - Pliant Therapeutics Reports Positive Results of Phase 1 Clinical Study Support Advancement of PLN-74809 for Idiopathic Pulmonary Fibrosis
April 8 2019 - ATS Foundation/Boehringer Ingelheim Pharmaceuticals Inc. research fellowship in idiopathic pulmonary fibrosis
https://www.eurekalert.org/pub_releases/2019-04/ats-afi040819.php
April 3 2019 - €21M Series A to Finance Belgian Biotech’s Regenerative Antibodies
https://www.labiotech.eu/medical/argenx-agomab-fibrosis-regenerative/
April 2 2019 - Immune cell turned biomarker: Predicting severity of lung scarring
April 2 2019 - Quantitative CT analysis of honeycombing area predicts mortality in idiopathic pulmonary fibrosis with definite usual interstitial pneumonia pattern: A retrospective cohort study
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0214278
April 1 2019 - Launceston researcher's key finding on fatal lung disease
March 28 2019 - Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(18)30508-3/fulltext
March 25 2019 - Cerenis Therapeutics and H4Orphan Pharma enter into exclusive negotiations to consider a strategic merger
March 27 2019 - Lamellar Biomedical Expands its Product Formulation and Process Capabilities to Realise the Potential of its LAMELLASOME™ Nucleic Acid Transfer (NAT) technology
March 27 2019 - VUMC and TGen Receive $6.1 Million in Grants to Study Deadly Lung Disease
March 25 2019 - Promedior Received Breakthrough Therapy Designation from FDA for PRM-151 in Idiopathic Pulmonary Fibrosis
March 21 2019 - Pirfenidone a ‘feasible treatment option’ for advanced IPF
March 20 2019 - Study: Protein linked to cancer growth drives deadly lung disease
https://www.eurekalert.org/pub_releases/2019-03/cmc-spl031919.php
March 19 2019 - Saracatinib Receives Orphan Drug Designation for Idiopathic Pulmonary Fibrosis
March 15 2019 - Complex Dosing, Polypharmacy Common With Interstitial Lung Disease
March 15 2019 - Lung Microbes Promote Pulmonary Fibrosis In Mice Read more from Asian Scientist Magazine at: https://www.asianscientist.com/2019/03/in-the-lab/lung-microbiome-pulmonary-fibrosis/
https://www.asianscientist.com/2019/03/in-the-lab/lung-microbiome-pulmonary-fibrosis/
March 092019 - Hydrogel-based delivery of Il-10 improves treatment of bleomycin-induced lung fibrosis in mice
https://www.sciencedirect.com/science/article/pii/S0142961219301085?via%3Dihub
March 08 2019 - Gene Expression Changes Associated with Nintedanib Treatment in Idiopathic Pulmonary Fibrosis Fibroblasts: A Next-Generation Sequencing and Bioinformatics Study
https://www.mdpi.com/2077-0383/8/3/308/htm
March 08 2019 - Daewoong’s pulmonary fibrosis treatment wins government support
http://www.koreabiomed.com/news/articleView.html?idxno=5298
March 07 2019 - No survival benefit of add-on cyclophosphamide following IPF exacerbation
March 06 2019 - Pulmonary Fibrosis Foundation Updates Warning On Stem Cell Therapies Outside Clinical Trials
March 06 2019 - ERT Launches Industry's First Purpose-Built, Connected Spirometry Solution
February 26 2019 - Preliminary result of definitive radiotherapy in patients with non-small cell lung cancer who have underlying idiopathic pulmonary fibrosis: comparison between X-ray and proton therapy
https://ro-journal.biomedcentral.com/articles/10.1186/s13014-019-1221-4
February 25 2019 - Algernon Pharmaceuticals Expands Its Research Program to Include Idiopathic Pulmonary Fibrosis
February 20 2019 - A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis
https://erj.ersjournals.com/content/53/3/1801992
February 20 2019 - Tyler doctors develop drug that could reverse lung scarring
February 12 2019 - AdAlta targeting human trials for lead i-body fibrosis candidate in under a year
February 11 2019 - CT Honeycombing in Interstitial Lung Disease Linked to Higher Mortality Rates
February 07 2019 - TRAIL signals through the ubiquitin ligase MID1 to promote pulmonary fibrosis
https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-019-0786-x
February 072019 - Evotec and Galapagos enter into collaboration in the field of fibrosis
February 04 2019 - SQI Pertners with Toronto's University Health Network on Multiplexed Testing to Improve the Success of Organ Transplantation
February 01 2019 - KIT National Center for Efficacy Evaluation of Respiratory Disease one step further toward healthy respiratory organs
https://www.eurekalert.org/pub_releases/2019-02/nrco-knc020119.php
February 01 2019 - New clues discovered to lung transplant rejection
https://medicine.wustl.edu/news/new-clues-discovered-to-lung-transplant-rejection/
February 01 2019 - If Scarring is an Orchestra, PU.1 is the Conductor
January 24 2019 - New Idiopathic Pulmonary Fibrosis Treatment Safe, Likely Effective
January 24 2019 - Summary of 2018 Idiopathic Pulmonary Fibrosis Diagnostic Guidelines
January 23 2019 - 'Infinite hug' mechanism may be key to lung fibrosis: U of T research
https://www.utoronto.ca/news/infinite-hug-mechanism-may-be-key-lung-fibrosis-u-t-research
January 21 2019 - Northwestern Memorial Hospital First in the U.S. to Perform Robotic Lung Volume Reduction Surgery
January 17 2019 - Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
https://www.nature.com/articles/s41590-018-0276-y
January 17 2019 - Synairgen’s LOXL2 fibrosis drugs ready for phase II trials
January 16 2019 - Bridge Biotherapeutics Announces FDA Orphan Drug Designation for BBT-877 in Idiopathic Pulmonary Fibrosis (IPF)
January 14 2019 - Life-threatening lung disease averted in experimental models
https://medicalxpress.com/news/2019-01-life-threatening-lung-disease-averted-experimental.html
January 10 2019 - Further investigation of omeprazole warranted in patients with IPF
January 07 2019 - First-in-human trial of senolytic drugs encouraging
https://www.sciencedaily.com/releases/2019/01/190107112944.htm
January 07 2019 - Meta-analysis of gastroesophageal reflux disease and idiopathic pulmonary fibrosis
January 04 2019 - Lamellar to conduct multiple Business Development Meetings about its LAMELLASOME™ technology for safe and effective delivery of nucleic-acid based therapeutics at Biotech Showcase in San Francisco
January 04 2019 - Fibrocor and Galapagos sign partnership in fibrosis
https://apnews.com/6a9d99a0d34413ce8e5291c819a34369
January 04 2019 - Lung Transplant Recipients at Higher Risk for Lung Cancer Than General Population
https://www.oncnet.com/news/lung-transplant-recipients-higher-risk-lung-cancer-general-population
January 04 2019 - Promedior Announces Pivotal Path for PRM-151 in Idiopathic Pulmonary Fibrosis Following Positive End-of-Phase 2 Meeting with FDA
January 03 2019 - Obstacles to early treatment of idiopathic pulmonary fibrosis: current perspectives
IPF Today
Vienna, VA
United States
info